New study: Impact of the pharmaceutical incentives and rewards in Europe

New study: Impact of the pharmaceutical incentives and rewards in Europe

May 28, 2018

Today, the European Commission has published our study on the economic impact of supplementary protection certificates, pharmaceutical incentives and rewards in Europe.

Using a novel measure of ‘Effective protection period’ as well as a unique, new dataset we assess the economic impact of supplementary protection certificates (SPC’s) and the pharmaceutical incentives and rewards in the EU.

Learn more about the study

For further information, please contact Christian Jervelund